Vintage Pharm’s Generic Dextroamphetamine Sulfate Receives Approval In US
Enforcement Report - Week of May 31, 2017
A generic drug maker owned by Endo International Plc has reached a $39 million settlement with the U.S. government and 47 states stemming from the unlawful labeling of multivitamins that contained fluoride.
Vintage`s Generic Dutasteride approved in US for Symptomatic BPH In Men
Vintage recalls Ranitidine Syrup due to Out of Specification results
Vintage Pharmaceuticals LLC recalls AMPICILLIN CAPSULES due to Incorrect Labeling
Vintage`s Generic Temazepam (7.5, 15, 22.5, 30 Mg) Approved in USA For Insomnia
Vintage`s Generic Clindamycin Phosphate (Eq 1% Base) Approved in USA For Bacterial Infections
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco